Atherosclerosis
Volume 204, Issue 1 , Pages 34-39, May 2009

Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta

  • Federica Lodi

      Affiliations

    • Department of Pharmacology, School of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain
    • Hospital Joan March, 08110 Bunyola, Mallorca, Spain
  • ,
  • Rosario Jimenez

      Affiliations

    • Department of Pharmacology, School of Pharmacy, Universidad de Granada, 18071 Granada, Spain
  • ,
  • Laura Moreno

      Affiliations

    • Department of Pharmacology, School of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain
    • Hospital Joan March, 08110 Bunyola, Mallorca, Spain
  • ,
  • Paul A. Kroon

      Affiliations

    • Institute of Food Research, Colney Lane, NR4 7UA Norwich, United Kingdom
  • ,
  • Paul W. Needs

      Affiliations

    • Institute of Food Research, Colney Lane, NR4 7UA Norwich, United Kingdom
  • ,
  • David A. Hughes

      Affiliations

    • Institute of Food Research, Colney Lane, NR4 7UA Norwich, United Kingdom
  • ,
  • Celestino Santos-Buelga

      Affiliations

    • Laboratorio de Nutrición y Bromatologia, Facultad de Farmacia, Universidad de Salamanca, 37007 Salamanca, Spain
  • ,
  • Ana Gonzalez-Paramas

      Affiliations

    • Laboratorio de Nutrición y Bromatologia, Facultad de Farmacia, Universidad de Salamanca, 37007 Salamanca, Spain
  • ,
  • Angel Cogolludo

      Affiliations

    • Department of Pharmacology, School of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain
    • Hospital Joan March, 08110 Bunyola, Mallorca, Spain
  • ,
  • Rocío Lopez-Sepulveda

      Affiliations

    • Department of Pharmacology, School of Pharmacy, Universidad de Granada, 18071 Granada, Spain
  • ,
  • Juan Duarte

      Affiliations

    • Department of Pharmacology, School of Pharmacy, Universidad de Granada, 18071 Granada, Spain
  • ,
  • Francisco Perez-Vizcaino

      Affiliations

    • Department of Pharmacology, School of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain
    • Hospital Joan March, 08110 Bunyola, Mallorca, Spain
    • Corresponding Author InformationCorresponding author at: Department of Pharmacology, School of Medicine, Universidad Complutense de Madrid, Av Complutense s/n, 28040 Madrid, Spain. Tel.: +34 913941477; fax: +34 913941465.

Received 22 January 2008; received in revised form 14 July 2008; accepted 4 August 2008. published online 18 September 2008.

Abstract 

Epidemiological studies have reported an inverse association between dietary flavonoid intake and mortality for ischemic heart disease. Quercetin reduces blood pressure and restores endothelial dysfunction in hypertensive animals. However, quercetin (aglycone) is usually not present in plasma, but it is rapidly metabolized during absorption by methylation, glucuronidation and sulfation. We have analyzed the vasorelaxant effects and the role on NO bioavailability and endothelial function of quercetin and its conjugated metabolites (quercetin-3-glucuronide, isorhamnetin-3-glucuronide and quercetin-3′-sulfate) in rat aorta. Thoracic aortic rings isolated from Wistar rats were mounted for isometric force recording and endothelial function was tested by measuring the vasorelaxant response to acetylcholine. NADPH-enhanced O2 release was quantified in homogenates from cultured aortic smooth muscle cells using lucigenin chemiluminescence. Unlike quercetin, the conjugated metabolites had no direct vasorelaxant effect, and did not modify endothelial function or the biological activity of NO. However, all metabolites (at 10μmol/L) prevented, at least partially, the impairment of endothelial-derived NO response under conditions of high oxidative stress induced by the SOD inhibitor DETCA. Furthermore, they protected the biological activity of exogenous NO when impaired by DETCA. Quercetin and quercetin-3′-sulfate (≥10μmol/L) or quercetin-3-glucuronide (100μmol/L) inhibited NADPH oxidase-derived O2 release. Quercetin and quercetin-3-glucuronide (1μmol/L) prevented the endothelial dysfunction induced by incubation with ET-1. These data indicate, for the first time, that the conjugated metabolites could be responsible for the in vivo protective activity of quercetin on endothelial dysfunction.

Keywords: Quercetin conjugates, Endothelial dysfunction, Nitric oxide, Oxidative stress

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0021-9150(08)00551-0

doi:10.1016/j.atherosclerosis.2008.08.007

Atherosclerosis
Volume 204, Issue 1 , Pages 34-39, May 2009